Byron Nash Renal Medullary Carcinoma Awareness Act of 2021

Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2021 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 4 January 2021

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 4 January 2021

   Introduced

   Introduced in House

   Source: IntroReferral

3. 4 January 2021

   Introduced

   Introduced in House

   Source: IntroReferral

4. 2 February 2021

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 4 January 2021 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 4 January 2021

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 4 January 2021

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 4 January 2021

  Open at official source

Sponsors

• Al Green · D · Sponsor
• Andy Barr · R · Cosponsor
• Rep. Carson, André [D-IN-7] · D · Cosponsor
• Bennie Thompson · D · Cosponsor
• Don Bacon · R · Cosponsor
• Michael Burgess · R · Cosponsor
• Donald Payne · D · Cosponsor
• Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
• Markwayne Mullin · R · Cosponsor
• · hsif00 · Standing

Related records

• related to → Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
• related to ← Byron Nash Renal Medullary Carcinoma Awareness Act of 2019